Clinical trial
Artemether-Lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in Mali
NCT02645604 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Artemether-Lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in Mali
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2016
- Completion date
- December 14, 2018
- Enrollment
- 154 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
accute falciparum malaria